<DOC>
	<DOCNO>NCT01608646</DOCNO>
	<brief_summary>In study , relationship DPD effect S-1 combine oxaliplatin chemotherapy investigate 200 patient gastrointestinal carcinoma .</brief_summary>
	<brief_title>Study DPD Predicting Efficacy Safety S-1 Plus Oxaliplatin Gastrointestinal Cancer</brief_title>
	<detailed_description>A new oral DPD inhibitory fluoropyrimidine ( DIF ) , S-1 , reportedly effective gastrointestinal carcinoma . In study , relationship activity DPD peripheral blood effect chemotherapy investigated 200 patient treated first-line S-1 combine platinum chemotherapy gastrointestinal carcinoma .</detailed_description>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Age ≧18 ; Histologically cytologically confirm gastrointestinal cancer； ECOG ≦2 ; Physician 's intention treat S1 combine platinum regimen disease status clinical judgment ; Life expectancy least three month ; Written inform consent participate trial ; History severe hypersensitivity reaction ingredient S1 oxaliplatin ; Inadequate hematopoietic function define : white blood cell ( WBC ) less 3,500/mm^3 absolute neutrophil count ( ANC ) less 1,500/mm^3 platelet less 80,000/mm^3 Inadequate hepatic renal function define : serum bilirubin great 1.5 time upper limit normal range alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) great 2.5 time ULN demonstrable liver metastasis great 5 time ULN presence liver metastases blood creatinine level great 2 time ULN Presence peripheral neuropathy ; Receiving concomitant treatment fluoropyrimidine drug flucytosine drug ; Women pregnant lactate fertile woman childbearing potential unless use reliable appropriate contraceptive method throughout treatment period ( Including male ) ; Psychiatric disorder symptom make participation patient difficult ; Concomitant illness might aggregate active , noncontrolled disease congestive heart failure , ischemic heart disease , uncontrolled hypertension arrhythmia six month ; Severe complication ( ) , e.g. , paresis intestine , ileus , radiographically confirm interstitial pneumonitis pulmonary fibrosis , glomerulonephritis , renal failure , poorlycontrolled diabetes ; Known DPD deficiency ; Receiving concomitant treatment sorivudine Brivudine within two month ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>S-1</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Dihydropyrimidine Dehydrogenase</keyword>
</DOC>